赣南医学院学报
贛南醫學院學報
공남의학원학보
JOURNAL OF GANNAN MEDICAL COLLEGE
2014年
3期
381-383
,共3页
陈金仙%顾晓霞%蔡树云%刘奕君%杨引
陳金仙%顧曉霞%蔡樹雲%劉奕君%楊引
진금선%고효하%채수운%류혁군%양인
滴鼻预处理%右美托咪定%依托咪酯%肌阵挛%注射痛
滴鼻預處理%右美託咪定%依託咪酯%肌陣攣%註射痛
적비예처리%우미탁미정%의탁미지%기진련%주사통
Pretreatment%Dexmedetomidine%Etomidate myoclonic%Injection pain
目的:观察右美托咪定术前滴鼻预处理对预防全身麻醉诱导期依托咪酯注射痛及肌阵挛的影响。方法:60例择期全麻手术者随机分为右美托咪定组(D 组)和对照组(N 组),各30例。D 组术前30 min 鼻内滴入右美托咪定(1.0μg·kg -1);N 组术前30 min 鼻内滴入同等剂量0.9%氯化钠溶液。麻醉诱导时每组均静注依托咪酯0.3 mg·kg -1。记录两组预给药前(T0)、给依托咪酯前(T1)及给依托咪酯后1 min(T2)、2 min(T3)的血压(BP)、心率(HR)、血氧饱合度(SPO2);采用词语等级评分法(VRS)评估依托咪酯注射痛;观察并记录静注依托咪酯后2 min 内肌阵挛发生情况。结果:与 T0比较,D 组 HR、MAP 在 T1、T2、T3明显降低(均<0.05),N 组 T2、T3明显降低(均<0.05);D 组 HR 在 T1、T2、T3较 N 组降低(均<0.05)。D 组 MAP、SPO2在 T1、T2、T3时点较N 组稍降低(均>0.05);D 组肌阵挛各级发生率均较 N 组降低(均<0.05);与 N 组比较,D 组依托咪酯注射痛的发生率和严重程度均明显降低(<0.05)。结论:右美托咪定术前鼻内滴注,能有效减轻麻醉诱导期依托咪酯注射痛,还可减少依托咪酯诱导所致肌阵挛的发生,提供更稳定的血流动力环境。
目的:觀察右美託咪定術前滴鼻預處理對預防全身痳醉誘導期依託咪酯註射痛及肌陣攣的影響。方法:60例擇期全痳手術者隨機分為右美託咪定組(D 組)和對照組(N 組),各30例。D 組術前30 min 鼻內滴入右美託咪定(1.0μg·kg -1);N 組術前30 min 鼻內滴入同等劑量0.9%氯化鈉溶液。痳醉誘導時每組均靜註依託咪酯0.3 mg·kg -1。記錄兩組預給藥前(T0)、給依託咪酯前(T1)及給依託咪酯後1 min(T2)、2 min(T3)的血壓(BP)、心率(HR)、血氧飽閤度(SPO2);採用詞語等級評分法(VRS)評估依託咪酯註射痛;觀察併記錄靜註依託咪酯後2 min 內肌陣攣髮生情況。結果:與 T0比較,D 組 HR、MAP 在 T1、T2、T3明顯降低(均<0.05),N 組 T2、T3明顯降低(均<0.05);D 組 HR 在 T1、T2、T3較 N 組降低(均<0.05)。D 組 MAP、SPO2在 T1、T2、T3時點較N 組稍降低(均>0.05);D 組肌陣攣各級髮生率均較 N 組降低(均<0.05);與 N 組比較,D 組依託咪酯註射痛的髮生率和嚴重程度均明顯降低(<0.05)。結論:右美託咪定術前鼻內滴註,能有效減輕痳醉誘導期依託咪酯註射痛,還可減少依託咪酯誘導所緻肌陣攣的髮生,提供更穩定的血流動力環境。
목적:관찰우미탁미정술전적비예처리대예방전신마취유도기의탁미지주사통급기진련적영향。방법:60례택기전마수술자수궤분위우미탁미정조(D 조)화대조조(N 조),각30례。D 조술전30 min 비내적입우미탁미정(1.0μg·kg -1);N 조술전30 min 비내적입동등제량0.9%록화납용액。마취유도시매조균정주의탁미지0.3 mg·kg -1。기록량조예급약전(T0)、급의탁미지전(T1)급급의탁미지후1 min(T2)、2 min(T3)적혈압(BP)、심솔(HR)、혈양포합도(SPO2);채용사어등급평분법(VRS)평고의탁미지주사통;관찰병기록정주의탁미지후2 min 내기진련발생정황。결과:여 T0비교,D 조 HR、MAP 재 T1、T2、T3명현강저(균<0.05),N 조 T2、T3명현강저(균<0.05);D 조 HR 재 T1、T2、T3교 N 조강저(균<0.05)。D 조 MAP、SPO2재 T1、T2、T3시점교N 조초강저(균>0.05);D 조기진련각급발생솔균교 N 조강저(균<0.05);여 N 조비교,D 조의탁미지주사통적발생솔화엄중정도균명현강저(<0.05)。결론:우미탁미정술전비내적주,능유효감경마취유도기의탁미지주사통,환가감소의탁미지유도소치기진련적발생,제공경은정적혈류동력배경。
Objectiye:To investigate the effects of etomidate injection pain and myoclonus given intranasal dexmedetomi-dine premedication on the induction of gereral anesthesia. Methods:Sixty cases undergone operation were randomly allo-cated to each group. Intranasal administrated dexmedetomidine1. 0 μg·kg - 1(group D n = 30)or given same volume of saline( group N n = 30)30 min before surgery. Blood pressure(BP),heart rate(HR),oxygen saturation(SPO2 )were recorded before drug(T0 ),to etomidate before(T1 )and to 1 min(T2 )、2 min(T3 )after etomidate. Scoring method used words(VRS)for etomidate injection pain score;observed and recorded myoclonus occurrence within 2 min after in-travenous etomidate. Results:There were no differences between two groups in all indexes before drug( > 0. 05). The SBP,HR,the VRS scores and myoclonus occurrence of group D were significantly lower than that of group N after drug(< 0. 05). SPO2 had no statistical significance between the two groups before and after drug( > 0. 05). Conclusions:These results suggest that the intranasal administration of dexmedetomidine in patients before operation is a safe and effec-tive preoperation medication,Not only can effectively reduce etomidate injection pain,but also significantly reduce myoc-lonus occurrence induced by etomidate to provide a more stable hemodynamic conditions.